Dova Pharmaceuticals Inc. 3 SEC Filings

Filed On	Filing
20 Dec 2018	Form 3: Zaccardelli David, President & CEO No securities owned
20 Dec 2018	Form 3: Hoitt Jason, Chief Commercial Officer No securities owned
26 Jun 2018	Form 3: Wysenski Nancy, Director No securities owned
06 Jun 2018	Form 3: Perceptive Advisors Llc, 10% owner and 2 others Holds 2,821,151 shares of Common Stock
01 Feb 2018	Form 3: Hahn Mark W, Chief Financial Officer Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Stalfort Sean, Director Holds 604,665 shares of Common Stock
28 Jun 2017	Form 3: Sapir Alex, Director Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Novak Alfred J, Director Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Manning Paul B, Director and 1 other Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Laliberte Kevin, Sr. VP, Product Development Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Jeffs Roger, Director Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Goldman Steven M., Director Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Blankenship Douglas, Chief Financial Officer Holds 0 shares of Common Stock
28 Jun 2017	Form 3: Allen Lee F Md PhD, Chief Medical Officer Holds 0 shares of Common Stock

Comments